CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Zandy Forbes

President and Chief Executive Officer, MeiraGTx

Search every verified Zandy Forbes interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Zandy Forbes, Ph.D., president and chief executive officer of MeiraGTx, discussed the company's approach to risk mitigation and pipeline development in a December 2024 episode of the Business of Biotech podcast. Forbes described her background as a public markets healthcare investor and postdoctoral fellow, and said that experience shaped her strategy of layering risk-reduction measures across MeiraGTx's operations, including a broad pipeline, in-house manufacturing, and optimization of gene therapy components. She stated that the company avoided focusing on indications requiring large systemic doses that could be potentially unsafe, instead prioritizing local delivery of small doses in immune-protected areas with human proof of concept. Forbes also highlighted MeiraGTx's work on a new method for controlling gene expression using small molecules, which she said could precisely regulate the output of DNA-encoded RNA products such as GLP-1, leptin, amylin, antibodies, and nucleases. She credited the company's chief operating officer and CFO, Rich Jaru, with whom she has worked since 2021, as a trusted collaborator in building the company. Forbes noted that this approach was designed to make MeiraGTx resilient to failures or market shifts, while also enabling the development of novel technologies.

Recent appearances

  • The Future of Genetic Medicine with Zandy Forbes, CEO of MeiraGTx

    February 10, 2026 · 📺 Oxford+

    What compels a scientist to leave academia for the high-stakes world of finance and then become the CEO of a publicly-traded biotech company? In this episode of Oxford+, host Susannah de Jager sits down with Zandy Forbes, the CEO and co-founder of MeiraGTx. Zandy shares her fascinating career journey, explaining how her experience as a hedge fund analyst shaped her unique approach to building a resilient, multi-asset genetic medicine company. They discuss MeiraGTx's pioneering work, from developing a mind-blowing technology that turns the body into a drug manufacturing facility to their su…

    Watch on YouTube ↗

  • Chardan Ophthalmology Conference Series - Rare Disease ft. MeiraGTx

    August 01, 2025 · 📺 Chardan

    MeiraGTx President and CEO, Zandy Forbes, hosted by Daniil Gataulin, PhD.... key programs to the audience um uh I'm Zandy Forbes the CEO of Mirror mirror is a genetic medicines company um established ...

    Watch on YouTube ↗

  • Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

    December 30, 2024 · 📺 Life Science Connect

    Zandy Forbes, Ph.D. learned about business risk mitigation in the riskiest of business environments. She was a public markets healthcare investor on Wall Street for well more than a decade. Her hedge fund experience followed the Human Frontiers/Howard Hughes postdoctoral fellowship at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center that was preceded by an Oxford Ph.D. in Molecular Genetics. Since 2015, she's been drawing from her immersion in both the business and science disciplines as President & CEO at Meira GTx. On this episode of the Business of Biotech, Dr.…

    Watch on YouTube ↗

  • MeiraGTx — Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

    April 27, 2023 · 📺 Chardan

    Chardan’s virtual 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit was held on April 24-25, 2023. Attendees heard directly from CEOs, CTOs, and Heads of Manufacturing representing companies with internal manufacturing, as well as CDMOs, on the latest considerations and technology for cell therapy and genetic medicines manufacturing. The format for this event was fireside chats alongside virtual manufacturing site tours and panel discussions. **This event is for current or prospective relationships of Chardan. If you would like to request more information contact corpaccess@…

    Watch on YouTube ↗

  • Alexandria Forbes, President and CEO of MeiraGTx interview: IDA Annual Conference 2023

    January 16, 2023 · 📺 IDA Ireland

    Alexandria Forbes, Ph.D. President and CEO of MeiraGTx speaks to Michael Lohan, IDA Ireland Divisional Manager for Life Sciences, Talent, Transformation & Innovation about new science, technological advancements in medicine, and equitable healthcare at our Annual Conference 2023. MeiraGTX is a pioneering company focused on gene therapy in terms of Curative medicine and Curative platforms for the next generation of serious and chronic diseases. #23annualconf. #InvestInIreland #WhyIreland

    Watch on YouTube ↗

  • A cure for blindness: The London-based company turning back the clock on serious diseases – MeiraGTx

    August 14, 2022 · 📺 Science Digest

    An interview with Zandy Forbes, President and CEO of MeiraGTx, the Shoreditch-based company that is using gene therapy to turn back the clock on serious diseases. They currently have six ongoing clinical trials, including one that has shown the potential to reverse the effects of blindness. https://meiragtx.com/ Shot and edited by Matthew Capon Produced by Callum Hoare

    Watch on YouTube ↗

  • Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit: MeiraGTx

    April 29, 2022 · 📺 Chardan

    On April 25-26, 2022, Chardan virtually hosted its 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit. The summit featured fireside chats alongside virtual manufacturing site tours and panel discussions and attendees heard from CEOs, CTOs, and Heads of Manufacturing representing companies with internal manufacturing, as well as CDMOs, on the latest considerations and technology for cell therapy and genetic medicines manufacturing.

    Watch on YouTube ↗

  • Building a Broad-based Gene Therapy Company - Dr. Alexandria Forbes

    April 20, 2022 · 📺 Carnegie Science Embryology

    Building a Broad-based Gene Therapy Company: From Molecular Genetics to Synthetic Biology. Presented by Dr. Alexandria Forbes of MeiraGTx. A Science in the Neighborhood public lecture. –––––––––– Dr. Forbes discusses how her background in academic research, the hedge fund industry, and biotech influenced the strategy underlying the formation of the gene therapy company MeiraGTx. She will give an overview of the company today, including the clinical pipeline, manufacturing capabilities, vector optimization technologies, and the development of a completely new synthetic mammalian riboswitch p…

    Watch on YouTube ↗

  • Interviews with RiboMed Speakers | Zandy Forbes

    December 17, 2021 · 📺 Instituto de Medicina Molecular João Lobo Antunes

    Zandy Forbes | MeiraGTx.

    Watch on YouTube ↗

  • The Future of Manufacturing Panel Chardan_GMMS2021

    April 29, 2021 · 📺 Chardan

    Panel Discussion with Zandy Forbes, PhD, President & Chief Executive Officer, MeiraGTx, Geoff MacKay, President & Chief Executive Officer, AVROBIO, and Andrey Zarur, PhD, Co-Founder, President & Chief Executive Officer, GreenLight Biosciences. Moderated by Gbola Amusa, MD, CFA

    Watch on YouTube ↗

  • MeiraGTx

    October 18, 2018 · 📺 Alliance for Regenerative Medicine

    Zandy Forbes, Ph.D., CEO New York, NY (NASDAQ: MGTX) MeiraGTx is a vertically integrated, clinical-stage gene therapy company with four ongoing clinical programs and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology. Led by an experienced management team, MeiraGTx has taken a portfolio approach by licensing, acquiring and developing technologies that give depth across both product candidates and indications. MeiraGTx’s i…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →